Tarsus Pharmaceuticals, Inc. [Rocket]

Financials

Income Statement

Cash Flow Statement

Segments

Credit Analysis

Tarsus Pharmaceuticals, Inc.

Segments

Annual | Quarterly | TTM

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	8-K	10-K	10-K	10-K	S-1/A
Revenues
License fees	23.9
Research and development	42.6

Mix
License fees	92.6%
Research and development	165.1%

Growth

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy